sb 216763 has been researched along with Nerve Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beech, BH; Beech, WK; Begum, AN; Chen, P; Cole, GM; Davies, P; Frautschy, SA; Hu, S; Jones, MR; Kim, PC; Ma, Q; Oh, MS; Ubeda, OJ; Yang, F | 1 |
| Alexander, J; Aronin, N; Chase, K; DiFiglia, M; Kegel, KB; Li, X; Reeves, PB; Sapp, E; Valencia, A | 1 |
2 other study(ies) available for sb 216763 and Nerve Degeneration
| Article | Year |
|---|---|
GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Caspase 3; Cells, Cultured; Disease Models, Animal; DNA Fragmentation; Enzyme Inhibitors; Gliosis; Glycogen; Glycogen Synthase Kinase 3; Hippocampus; Indoles; JNK Mitogen-Activated Protein Kinases; Maleimides; Maze Learning; Nerve Degeneration; Neurons; Phosphorylation; Rats; Rats, Sprague-Dawley; tau Proteins | 2009 |
Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
Topics: Analysis of Variance; Animals; Blotting, Western; Cell Fractionation; Cell Survival; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Glycogen Synthase Kinase 3; Huntingtin Protein; Huntington Disease; Indoles; Maleimides; Membrane Microdomains; Mice; Mice, Transgenic; Microscopy, Confocal; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Nuclear Proteins | 2010 |